TrialThe lancet. Gastroenterology & hepatology2023

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.

Kara L Kliewer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.